Diclofenac sodium
CAS No. 15307-79-6
Diclofenac sodium( Benfofen | Ecofenac | Voltaren )
Catalog No. M12146 CAS No. 15307-79-6
Diclofenac Sodium is a non-selective COX inhibitor with IC50 of 60 and 220 nM for ovine COX-1 and -2, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 41 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDiclofenac sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiclofenac Sodium is a non-selective COX inhibitor with IC50 of 60 and 220 nM for ovine COX-1 and -2, respectively.
-
DescriptionDiclofenac Sodium is a non-selective COX inhibitor with IC50 of 60 and 220 nM for ovine COX-1 and -2, respectively.(In Vitro):Diclofenac effectively blocks COX-1 mediated prostanoid production from U937 cell microsomes, with an IC50 of 7±3 nM.Diclofenac (1-60 μM; 1 day) induces neural stem cells (NSCs)death in a concentration-dependent manner.Diclofenac (10-60 μM; 6 hours) increases the expression of cleaved (activated) caspase-3.(In Vivo):Diclofenac (3 mg/kg, b.i.d., for 5 days) significantly increases faecal 51Cr excretion in rats, and such effect is also observed in squirrel monkeys after administrated of 1 mg/kg twice daily for 4 days.Diclofenac (10 mg/kg; administered via oral route just prior to induction of inflammation) shows in vivo anti-inflammatory activity in Wistar rats.
-
In VitroCell Viability Assay Cell Line:Neural stem cells (NSCs)Concentration:1, 3, 10, 30, 60 μMIncubation Time:1 day Result:Induction of cell death was concentration-dependent and the effect was not saturated at a concentration of up to 60 μM.Western Blot Analysis Cell Line:Neural stem cells (NSCs) Concentration:10, 30 or 60 μM Incubation Time:6 hours Result:The activation of caspase-3 was increased in a concentration-dependent manner.
-
In VivoAnimal Model:Male Sprague-Dawley rats (150±200 g) Dosage:3 mg/kg Administration:Oral administration, b.i.d., for 5 days Result:Resulted in a significant increase in faecal 51Cr excretion.Animal Model:Wistar rats (150-175 g) bearing Formalin-induced rat foot paw edema modelDosage:10 mg/kg Administration:Administered via oral route just prior to induction of inflammation Result:Showed in vivo anti-inflammatory activity (% edema inhibition=29.2, 1 h; 22.2, 3 h; 20, 6 h).
-
SynonymsBenfofen | Ecofenac | Voltaren
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1| COX-2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number15307-79-6
-
Formula Weight318.13
-
Molecular FormulaC14H10Cl2NNaO2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 64 mg/mL (201.17 mM); Water: 14 mg/mL (44.0 mM); DMSO: 64 mg/mL (201.17 mM)
-
SMILESc1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)Cl.[Na+]
-
Chemical NameBenzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monosodium salt
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kirchheiner J, et al. Br J Clin Pharmacol. 2003 Jan;55(1):51-6
molnova catalog
related products
-
Pelubiprofen
Pelubiprofen is an orally active, non-steroidal anti-inflammatory agent, a selective cyclooxygenase-2 (COX-2) inhibitor, which effectively reduces PGE(2) production by inhibiting COX activity.
-
COX-2-IN-6
COX-2-IN-6 is a potent, selective, and orally available cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 0.84 μM and a Ki of 69 nM.COX-2-IN-6 inhibits COX-2-driven PGE2 synthesis with an IC50 of 0.60 μM.COX-2-IN-6 is used to prevent colorectal cancer.
-
Hexahydrocurcumin
Hexahydrocurcumin is a selective, orally active COX-2 inhibitor and inactive against COX-1.
Cart
sales@molnova.com